Some suggest that FDA should create a separate division of rare and neglected diseases within the Center for Drug Evaluation and Research to bring the proper expertise to bear on the analysis of drug applications intended to treat such maladies.
Harkin discusses the need for a dedicated FDA division for rare diseases.
Share & report
More from Tom Harkin
Over 60 percent of people with disabilities who can work and want to work are not employed.
Mr. President, on behalf of Senator Alexander and myself, I do object to the unanimous consent request. The PRESIDING OFFICER. Objection is heard.
Mr. President, this is another sad, irresponsible day in the Senate. I say to my friend from Utah, he was here 2 years ago when we proposed the same exact unanimous consent request, and the Senator did not object. It also did not allow for…
Other voices in this conversation
